Raj Shrestha

Research activity per year

Filter

2024
MRFF PROSPECT trial: A multi-centre, open-label, parallel-group randomised controlled trial of predicting disease-modifying anti-rheumatic drug dose tapering response in rheumatoid and psoriatic arthritis with economic evaluation: A preliminary report from NHMRC A3BC Centre of Research Excellence trial consortium
Yi, J., Lassere, M., Portek, I., Hill, C., Wechalekar, M., Proudman, S., Whittle, S., Thomas, R., Gray, J., Keen, H., Liew, D., Youssef, P., Buchbinder, R., Sinnathurai, P., Laurent, R., Deveza, L., Hamid, M., Liu, X., Hong, L. & Sturgess, A. & 21 others, Ng, B., Lester, S., Goldblatt, F., Lynch, T., Purni, T., Chand, V., Cross, M., Shrestha, R., Xue, M., Lin, H., Tuli, J., Ruediger, C., Cayzer, A., Xing, J., Griggs, K., Altmann, C., Briggs, L., Roch, M., Yang, V., Lim, A. & March, L., Jun 2024, In: International Journal of Rheumatic Diseases. 27, Supplement 2, p. 40 1 p., e15172.
Research output: Contribution to journal › Meeting Abstract › peer-review

Open Access
2015
Glycated Hemoglobin: Predictor of Dyslipidemia and Atherogenicity in Diabetes Mellitus
Shrestha, R. K., Gyawali, P., Tuladhar, E. T., Sharma, V. K., Gupta, R. K. & Jha, B., Jun 2015, In: Journal of Hypertension. 33, S2, p. e12 1 p.
Research output: Contribution to journal › Meeting Abstract

Research output